REDUCTION OF COMPLICATIONS AND ASSOCIATED COSTS FOR TYPE 2 DIABETIC PATIENTS USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE UK

被引：0
|
作者：
Roze, S. [1 ]
Duteil, E. [2 ]
Hallas, N. [3 ]
de Portu, S. [4 ]
机构：
[1] HEVA HEOR Sarl, Lyon, France
[2] HEVA HEOR, Lyon, France
[3] Medtronic, Watford, England
[4] Medtron Int Sarl, Tolochenaz, Switzerland
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD90
引用
收藏
页码：A360 / A360
页数：1
相关论文
共 50 条
  • [31] Insulin Requirement Profiles of Short-Term Continuous Subcutaneous Insulin Infusion Therapy in Chinese Patients with Type 2 Diabetic Nephropathy
    Lin, Shuo
    Zhang, Kuixing
    Li, Ping
    Fang, Ke
    Zeng, Longyi
    DIABETES, 2019, 68
  • [32] Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients
    Pouwels, MJJ
    Tack, CJ
    Hermus, AR
    Lutterman, JA
    DIABETIC MEDICINE, 2003, 20 (01) : 76 - 79
  • [33] Efficacy of Subcutaneous Continuous Insulin Infusion Devices among Patients with or without Complications
    Gilligan, Patricia
    Zappe, Janet G.
    Dungan, Kathleen M.
    DIABETES, 2010, 59 : A254 - A254
  • [34] ENDURANCE EXERCISE IN TYPE-1 DIABETIC-PATIENTS TREATED BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    SCHEEN, AJ
    JANDRAIN, BJ
    PIRNAY, F
    LACROIX, M
    MOSORA, F
    LEFEBVRE, PJ
    DIABETOLOGIA, 1993, 36 : A21 - A21
  • [35] The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients
    Meyer, L
    Bohme, P
    Delbachian, I
    Lehert, P
    Cugnardey, N
    Drouin, P
    Guerci, B
    DIABETES CARE, 2002, 25 (12) : 2153 - 2158
  • [36] Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus
    Nielsen, S
    Kain, D
    Szudzik, E
    Dhindsa, S
    Garg, R
    Dandona, P
    DIABETES EDUCATOR, 2005, 31 (06): : 843 - 848
  • [37] Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
    Nakamura, Tomoaki
    Hirota, Yushi
    Hashimoto, Naoko
    Matsuda, Tomokazu
    Takabe, Michinori
    Sakaguchi, Kazuhiko
    Ogawa, Wataru
    Seino, Susumu
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (01) : 48 - 50
  • [38] Comparison of effectiveness of continuous subcutaneous insulin infusion with daily insulin injection in a Chinese population of Type I diabetic patients
    Yi, Qianqian
    Wu, Zhiyu
    Dong, Junhua
    Zhang, Ningning
    Li, Qiuyue
    Gao, Na
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (07) : 1517 - 1522
  • [39] THE PHARMACOKINETICS OF INSULIN AFTER CONTINUOUS SUBCUTANEOUS INFUSION OR BOLUS SUBCUTANEOUS INJECTION IN DIABETIC-PATIENTS
    KOBAYASHI, T
    SAWANO, S
    ITOH, T
    KOSAKA, K
    HIRAYAMA, H
    KASUYA, Y
    DIABETES, 1983, 32 (04) : 331 - 336
  • [40] Carbohydrate-to-insulin ratio in type 1 diabetic patients treated with continuous subcutaneous insulin infusion therapy (CSII)
    Gonzalez, C.
    Orellana, I.
    Corcoy, R.
    Alcantara, V.
    Chico, A.
    DIABETOLOGIA, 2013, 56 : S444 - S444
12345